APA (7th ed.) Citation

HG, R., P, S., MM, H., M, C., MJ, M., K, W., . . . JJ, A. (2025). Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: A CIBMTR analysis. Blood advances, 9(21), 5489. https://doi.org/10.1182/bloodadvances.2025016149

Chicago Style (17th ed.) Citation

HG, Rangarajan, et al. "Real-world Outcomes of Infections Following Tisagenlecleucel in Patients with B-cell ALL: A CIBMTR Analysis." Blood Advances 9, no. 21 (2025): 5489. https://doi.org/10.1182/bloodadvances.2025016149.

MLA (9th ed.) Citation

HG, Rangarajan, et al. "Real-world Outcomes of Infections Following Tisagenlecleucel in Patients with B-cell ALL: A CIBMTR Analysis." Blood Advances, vol. 9, no. 21, 2025, p. 5489, https://doi.org/10.1182/bloodadvances.2025016149.